Diphtheria Vaccine Market to Reach $8,188.3 Million in 2035, Growing at 5.1% CAGR

Diphtheria vaccine market valued at $5,016.1 million in 2025 and is projected to reach $8,188.3 million by 2035, growing at a CAGR of 5.1% during the forecast period (2026-2035). The market comprises vaccines developed to provide immunity against diphtheria, commonly administered as part of combination immunization schedules. The market is experiencing steady global growth driven by the continued emphasis on routine immunization, increasing awareness of vaccine-preventable diseases, and expansion of national vaccination coverage programs. Growth is further supported by rising birth rates in emerging economies, government-funded immunization initiatives, and global health campaigns focused on disease eradication. The integration of combination vaccines that protect against multiple diseases, along with advancements in vaccine formulation and cold-chain logistics, is reinforcing long-term market expansion. According to global health organizations such as the World Health Organization and UNICEF, widespread immunization programs and disease surveillance systems have significantly improved vaccine accessibility and coverage worldwide. These organizations maintain extensive datasets on immunization rates, disease incidence, and pediatric populations, which are critical for forecasting vaccine demand and optimizing supply chains globally.

Browse the full report description of “Diphtheria Vaccine Market Size, Share & Trends Analysis Report by Type (DTaP, DT, Td, and Tdap), By Application (Adolescents, Adults, Infants, and Children) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/diphtheria-vaccine-market

Key Statistics: Diphtheria Vaccine at a Glance

• The World Health Organization recommends routine diphtheria vaccination covering over 90% of infants globally through national immunization programs.
• More than 110 million infants receive DTP-containing vaccines annually, forming the core demand base for diphtheria vaccines.
• Global immunization efforts have reduced diphtheria cases by over 95% compared to pre-vaccine eras, sustaining consistent demand for booster doses across adolescents and adults.

Key Innovators Driving Diphtheria Vaccine Transformation

The key players in the diphtheria vaccine market include GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Sinopharm Group Co., Ltd, among others.

• In June 2025, Sanofi expanded its vaccine manufacturing capabilities to increase the global supply of combination vaccines, including those for diphtheria, tetanus, and pertussis.
• In April 2025, GlaxoSmithKline plc advanced research initiatives on next-generation combination vaccines focused on immunogenicity and duration of protection against diphtheria and other infectious diseases.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Sinopharm Group Co., Ltd, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Diphtheria Vaccine Market Report Segment

By Type

• DTaP
• DT
• Td
• Tdap

By Application

• Adolescents
• Adults
• Infants
• Children

Global Diphtheria Vaccine Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/diphtheria-vaccine-market